We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.00 | 17.50 | 18.50 | 18.00 | 18.00 | 18.00 | 66,018 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/6/2018 16:44 | Market launch for LPLDL® capsules in GermanyThis RNS was not RNS Reach. hTtp://www.londonsto | parob | |
05/6/2018 16:39 | that was a very strong movement this pm. premium being paid at close for smallish amounts. going to get very interesting very soon. | shrewdmole | |
05/6/2018 16:35 | To draw attention to the product launch and create interest in the market...could be released as an RNS Reach. | colinzeal | |
05/6/2018 16:19 | Have we not already had the seed rns? Why would we have another? | pglancy | |
05/6/2018 16:07 | Buying ahead of possible SEED RNS? Nice to hear talk of ii buying in too! | deeppockets | |
05/6/2018 14:33 | got them with an at best order. | belgrano2 | |
05/6/2018 14:25 | struggling to buy right now on iii, will only take at best orders.. come on, whos trying to grab all the stock...own up... not for an eye watering amount either. | belgrano2 | |
05/6/2018 14:04 | Thanks manc. The usual quality read.very interesting stats as well as comment on fibre and sugar and how sweetbiotix can fulfil the gap in our diets. | paulhoodwinked | |
05/6/2018 13:58 | hxxp://lemminginvest | manc10 | |
05/6/2018 13:56 | Guys haven't had time to read posts but broker called to ask if offload a few. Current bid is 69.2p - almost mid price- for 50k. Those ii want more. | shrewdmole | |
05/6/2018 13:40 | Hi. Could someone let me know the Seed website address. Googling seed is sending me on a wild goose chase! | suzypink | |
05/6/2018 13:25 | Rayrac you plank! You say this is a big boys game and I agree. Is a $10 billion dollar dairy company not big enough for you? It is for me! | speccy1 | |
05/6/2018 12:57 | Competition is good, not a negative. Our Universities are full of developing sugar, salt and saturated fat reduction and replacement. <1% will ever see a production run never mind be seen on any shelves or used in any Commercial Plant or Restaurant chains. | pj 1 | |
05/6/2018 12:43 | DuPont are mentioned in the link above by parob, as been involved with the same developments as opti. If they are not partnering opti, then not good? You’ve got to scroll down and read from there. | rayrac | |
05/6/2018 12:26 | Ray - fair point re the cash. Could you elaborate on the DuPont reference, please? Are they developing similar products? | m4rtinu | |
05/6/2018 12:16 | Thanks parob....very easy to understand...nice... | bobdown2 | |
05/6/2018 11:49 | Still won’t touch it...not till it strikes a really decent cash generating deal. There’s no sign of it yet and, if DuPont are not in as a partner, then there’s likely to be trouble ahead. It’s looking more and more like a big boy only game! | rayrac | |
05/6/2018 11:47 | aspex. I am quite sure that if HY Revenues are impressive then a Trading update will be issued extremely promptly. | pj 1 | |
05/6/2018 11:29 | Thanks Parob, a good read. | rafboy | |
05/6/2018 11:12 | H1 ended last week. Some statement showing revenue progress should be quite easy to arrive at given the very small numbers to collate. | aspex | |
05/6/2018 11:07 | We need something to take us away from the 60s/70s for good. Hopefully coming soon. | rafboy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions